ph1 community still excited one year after the approval of lumasiran
Published 2 years ago • 358 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:16
alnylam, and the ph1 community, waiting for the fda to approve lumasiran
-
5:00
fda approves lumasiran to treat primary hyperoxaluria type 1
-
1:38
lumasiran effective in advanced primary hyperoxaluria type 1
-
7:22
understanding patient & carers experiences with primary hyperoxaluria type 1 (ph1) and lumasiran
-
3:39
kim – living with primary hyperoxaluria type 1
-
3:25
integrating ems iso 14001:2015 and ohsms iso 45001:2018
-
4:50
efficient and simplified lab ph measurements with wtw inolab® ph 7110
-
2:20
growing up with a rare kidney disease
-
2:10
study results demonstrate favourable efficacy and safety of lumasiran for ph1
-
1:26
diagnosing primary hyperoxaluria type 1 (ph1)
-
5:10
illuminate-c, a single arm, phase 3 study of lumasiran in patients with primary hyperoxaluria type 1
-
1:40
what is primary hyperoxaluria type 1?
-
1:27
medical management options for primary hyperoxaluria type 1
-
2:37
gene therapy for primary hyperoxaluria type 1 (ph1)
-
2:17
the skinner family - living with primary hyperoxaluria type 1 (ph1)
-
1:21
arid1a deficiency linked to metastasis, chemoresistance of lung cancer cells
-
2:54
seth - living with primary hyperoxaluria type 1 (ph1)
-
5:35
explaining sparsentan’s full fda approval and other iga nephropathy therapeutic developments
-
2:59
ph1 patient recalls her many challenges (e.g., no friends, urine pouch, covid-19)
-
1:40
easl studio s5e05 promo: jhep live: the new nomenclature for sld